| Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms AM Baig, A Khaleeq, U Ali, H Syeda ACS chemical neuroscience 11 (7), 995-998, 2020 | 2794 | 2020 |
| Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2 AM Baig CNS neuroscience & therapeutics 26 (5), 499, 2020 | 378 | 2020 |
| Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulers. AM Baig Journal of medical virology 93 (5), 2021 | 301 | 2021 |
| Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome AM Baig ACS chemical neuroscience 11 (24), 4017-4020, 2020 | 150 | 2020 |
| Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19) AM Baig, EC Sanders Journal of medical virology 92 (10), 1845-1857, 2020 | 146 | 2020 |
| Updates on what ACS reported: emerging evidences of COVID-19 with nervous system involvement AM Baig ACS Chemical Neuroscience 11 (9), 1204-1205, 2020 | 76 | 2020 |
| In Vitro Efficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 Genotype AM Baig, J Iqbal, NA Khan Antimicrobial agents and chemotherapy 57 (8), 3561-3567, 2013 | 65 | 2013 |
| Pathogenesis of amoebic encephalitis: are the amoebae being credited to an ‘inside job’done by the host immune response? AM Baig Acta tropica 148, 72-76, 2015 | 59 | 2015 |
| Computing the effects of SARS-CoV-2 on respiration regulatory mechanisms in COVID-19 AM Baig ACS Chemical Neuroscience 11 (16), 2416-2421, 2020 | 55 | 2020 |
| Novel chemotherapeutic strategies in the management of primary amoebic meningoencephalitis due to Naegleria fowleri AM Baig, NA Khan CNS neuroscience & therapeutics 20 (3), 289, 2014 | 51 | 2014 |
| Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri AM Baig ACS chemical neuroscience 7 (8), 1026-1029, 2016 | 46 | 2016 |
| Acanthamoeba and bacteria produce antimicrobials to target their counterpart J Iqbal, R Siddiqui, NA Khan Parasites & vectors 7, 1-6, 2014 | 35 | 2014 |
| Counting the neurological cost of COVID-19 AM Baig Nature Reviews Neurology 18 (1), 5-6, 2022 | 33 | 2022 |
| Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris H Kulsoom, AM Baig, R Siddiqui, NA Khan Experimental parasitology 145, S115-S120, 2014 | 31 | 2014 |
| Evidence of a M1-muscarinic GPCR homolog in unicellular eukaryotes: featuring Acanthamoeba spp bioinformatics 3D-modelling and experimentations AM Baig, HR Ahmad Journal of Receptors and Signal Transduction 37 (3), 267-275, 2017 | 26 | 2017 |
| Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer AM Baig, NA Khan, V Effendi, Z Rana, HR Ahmad, F Abbas Anti-cancer drugs 28 (1), 75-87, 2017 | 26 | 2017 |
| Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp. AM Baig, Z Rana, S Tariq, S Lalani, HR Ahmad ACS chemical neuroscience, 2017 | 25 | 2017 |
| Neurological manifestations of COVID-19 D Kanwar, AM Baig, M Wasay JPMA. The Journal of the Pakistan Medical Association 70 (5 (Suppl 3)), S101, 2020 | 21 | 2020 |
| Tackling infection owing to brain-eating amoeba AM Baig, NA Khan Acta tropica 142, 86-88, 2015 | 20 | 2015 |
| Primary amoebic meningoencephalitis: amoebicidal effects of clinically approved drugs against Naegleria fowleri. AM Baig, HK Huma Kulsoom, NA Khan | 19 | 2014 |
Areeba KhaleeqAga Khan UniversityVerified email at aku.edu
